Abstract
Introduction
This analysis examines the historical and forecast performance for Abbott in
the prescription pharmaceutical sector. The profile encompasses global company
strategy, portfolio and pipeline analysis and assessment of financial
performance, with 1-6 year sales forecasts for key drugs. An interactive
forecasting and analysis tool provides continually updated quantitative and
qualitative information.
Key reasons to purchase this research
- Benchmark Abbott' s performance against key rivals in the prescription
pharmaceutical sector
- Discover how Abbott has utilised M&A to become one of the worlds largest
multi-disciplinary healthcare companies
- Investigate the strategies being employed by Abbott to overcome an under
strength pipeline and various litigation proceedings
| 
View Cart
